ArticleBMC endocrine disorders2025
Diabetes mellitus screening and its associated factors among women in Lesotho: evidence from the 2023-2024 demographic and health survey.
Article in BMC endocrine disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDiabetes screening is one of the simpler methods for preventing and lowering the disease's morbidity and mortality. Screening for gestational diabetes is a crucial component of obstetric care, as it negatively affects the life of both the mother and the fetus. There is a high prevalence of obesity, diabetes, high blood pressure, and tobacco use in Lesotho. This highlights the significance of bolstering prevention and treatment initiatives in the country. Therefore, this study is intended to assess diabetes screening and its associated factors among women aged 15-49 years using the 2023-24 Lesotho demographic and health survey dataset.
methodsA cross-sectional study was employed using data from the most recent national representative dataset. A total sample of 3,297 women aged between 15 and 49 years was included in the study. Data extracted from the Lesotho Demographic and Health Survey 2023-24 data sets were cleaned, recoded, and analyzed using STATA/SE version 14.0 statistical software. Multilevel logistic regression was used to determine the factors associated with the outcome variable. Finally, variables with a p-value less than 0.05 were declared statistically significant.
resultsIn the current study, 29.18% (95% CI: 27.65%-30.75%) of women aged 15-49 years in Lesotho were screened for diabetes mellitus. Of these, 1.40% of them had high blood sugar or diabetes, and 54.35% of women were diagnosed in the last twelve months. Age of respondents [AOR = 3.53; 95% CI (2.80, 4.46)], maternal occupation [AOR = 1.38; 95% CI (1.15, 1.65)], wealth status [AOR = 1.43; 95% CI (1.07, 1.91)], and visiting a healthcare facility in the last 12 months [AOR = 1.31; 95% CI (1.09, 1.57)] were statistically significantly associated with diabetes screening.
conclusionLess than one in three women aged 15 to 49 years were screened for diabetes in Lesotho. Advanced age, working women, wealthier households, and visiting a healthcare facility in the last 12 months were associated with higher odds of diabetes screening. Therefore, women's empowerment, regular visits to healthcare facilities, and awareness creation for young women are recommended to improve diabetes screening practices among women.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.